<DOC>
	<DOCNO>NCT02737384</DOCNO>
	<brief_summary>The purpose study evaluate selective depletion na誰ve CD45RA+ T cell allogenic peripheral blood stem cell graft child transplant combined immune deficiency . The aims procedure prevent graft versus host disease ( GVHD ) preserve anti-infectious response donor memory T lymphocytes .</brief_summary>
	<brief_title>Hematopoietic Stem Cells Transplantation Children With Combined Immunodeficiency ( CID )</brief_title>
	<detailed_description>Combined immunodeficiency ( CIDs ) heterogeneous group primitive immunodeficiency ( PID ) , affect T cell development , function . These inherited condition cure allogeneic hematopoietic stem cell transplantation ( HSCT ) . These procedure high risk morbidity mortality graft versus host disease ( GVHD ) , rejection graft serious infection , especially population child PID . GVHD frequent severe donor identical sibling and/or present HLA-mismatch . GVHD require high immunosuppression prevention treatment , therefore impedes immunity infection . In vitro animal model suggest GVHD mediate na誰ve T cell . The aim study decrease rate severity GVHD selective depletion na誰ve CD45RA+ T cell allogeneic hematopoietic stem cell graft patient CIDs high risk severe GVHD , preserve immunity pathogen population high vulnerability infection . The project aim , first , show improvement rejection-free GVH-free survival 12 month post-transplant , secondly , show decrease viral infection , ass immune reconstitution kinetic quality specific antiviral response , engraftment na誰ve cell deplete allograft .</detailed_description>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<criteria>Patient 12 month 18 year Combined immunodeficiency know molecular diagnosis unknown , correspond pCID study 's definition Hematopoietic stem cell Transplantation plan one follow donor : sibling 1 2 HLA antigen mismatch parent 10/10 9/10 identical unrelated donor : 10/10 9/10 identical Consent form sign child 's legal guardian Patient use effectiveness contraception trial Affiliated beneficiary health insurance regimen WiskottAldrich syndrome Ongoing pregnancy Positive HIV PCR Contraindication hematopoetic stem cell transplantation</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Combined immunodeficiency</keyword>
	<keyword>hematopoietic stem cell transplantation</keyword>
	<keyword>CD45RA</keyword>
	<keyword>primitive immunodeficiency</keyword>
	<keyword>pediatric transplantation</keyword>
	<keyword>CD45RA depletion</keyword>
</DOC>